Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.

Journal of chemotherapy (Florence, Italy) - 1 Apr 2007

Perilli M, Segatore B, Tavio M, Setacci D, Celenza G, De Santis F, Pellegrini C, Rossolini G M, Amicosante G

Abstract excerpt

The present work was undertaken to study the ability of ceftazidime and ceftibuten to selectin vitro Escherichia coli HB101 harboring bla(TEM-1) beta-lactamase gene. Minimum inhibitory concentrations (MICs) of ceftazidime and ceftibuten were increased by a factor of 32, overcoming in the case of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to beta-Lactamases
Share to Ceftazidime

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cephalosporin Resistance

Share to Cephalosporins

Share to Escherichia coli

Share to Gene Expression Profiling

Share to Microbial Sensitivity Tests

Source

Identifiers

PMID: 17434819
DOI: 10.1179/joc.2007.19.2.123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17434819-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.PMID 17434819Read ↗

Microbiologic profile of ceftibuten, a new oral cephalosporin.Semantic proximity Read ↗

Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.Semantic proximity Read ↗

Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.Semantic proximity Read ↗

Effect of cefoxitin and clindamycin on selection of derepressed mutants in Enterobacter cloacae.Semantic proximity Read ↗

Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.Semantic proximity Read ↗

Genomic Modification of TonB and Emergence of Small-Colony Phenotype in VIM- and NDM-Producing Escherichia coli following Cefiderocol Exposure In Vitro.Semantic proximity Read ↗

In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol.Semantic proximity Read ↗

Environmental reservoir of resistance genes for the last resort antibiotic CefiderocolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.